US Food and Drug Administration
Dr. Joshi is serving as a clinical pharmacology reviewer within the Office of Clinical Pharmacology (OCP) at the U.S Food and Drug Administration (FDA). Dr. Joshi’s training and research background are in the field of pharmacokinetics and its applications in translational and clinical pharmacology sciences. Since joining the FDA, he has contributed to the review of various IND, NDA, and BLA submissions across multiple therapeutic areas. Apart from the review work, he has contributed to various research projects and received recognitions and awards for his contributions at FDA. Additionally, he is serving as the clinical pharmacology subject matter expert on a team that provides oversight to the external research activities in the infectious diseases area. He has also participated in the review of internal regulatory research proposals and external research contracts in the infectious diseases area.
Disclosure information not submitted.
Monday, January 10, 2022
11:30 AM – 12:30 PM ET
Wednesday, January 12, 2022
1:30 PM – 2:00 PM ET
Wednesday, January 12, 2022
4:45 PM – 5:45 PM ET
Thursday, January 13, 2022
4:15 PM – 5:15 PM ET
.png)